Bridging Academia and Industry for Breakthrough Innovation

Join top VCs, academic innovators and biopharma leaders at the inaugural BioCentury Grand Rounds - Europe in Cambridge, U.K., Sept. 17-19, 2025.

Examine the latest advances in disease biology, therapeutic modalities and enabling technologies with the experts shaping the future of medicine

Explore cutting-edge science with commercial potential and tackle key translational challenges

Gain industry insights through presentations by emerging biotechs and academic innovators

Schedule partnering meetings with VCs, pharma executives and leading academics

Build your portfolios, pipelines and networks at the academia-industry interfaceEarly bird rates end July 11, 2025

Speakers

Kate Bingham

Managing Partner

SV Health Investors

Shaun Grady

Chair, U.K.

AstraZeneca

Steve Jackson

Professor of Biology, Cambridge and Group Leader

Cancer Research UK

James Sabry, M.D., Ph.D.

EVP and CBO

BioMarin

Patrick Vallance, KCB

Minister of State for Science, Research and Innovation

Department for Science, Innovation and Technology

Sarah Teichmann

Professor and Chair

Cambridge Stem Cell Institute

Why Should I Attend?

Discover cutting-edge research with commercial potential, connect with partners who can accelerate translation and explore new opportunities to expand your portfolio and pipeline.

Network, partner and debate with:

VCs and PEs
Biopharma R&D and BD&L Leaders
Biotech C-Suite
Academic Innovators
Financial Dealmakers

Steering Committee

BioCentury's Scientific Advisory Board brings together top leaders from pharma, biotech, venture and academia and serves as a Steering Committee for the Grand Rounds R&D conference.

Amy Abernethy, M.D., Ph.D.

Co-founder

Highlander Health

Noubar Afeyan, Ph.D.

Founder & CEO

Flagship Pioneering

Houman Ashrafian, D.Phil.

EVP of R&D

Sanofi

Kate Bingham

Managing Partner

SV Health Investors

Melissa Bonner, Ph.D.

Chief Scientific Officer

nChroma Bio Inc.

Luciana Borio, M.D.

Venture Partner

ARCH Venture Partners

What Will I Learn?

Highlights:

Discovering Disease Biology: Insights into emerging disease areas and the untapped potential of underserved indications

Accelerating Therapeutic Modalities: Addressing the limits of existing approaches and pioneering new molecular entities

Enabling Technologies, Empowered: Integrating engineering and medicine to drive breakthroughs in biology, drug discovery and diagnostics

Share your Story on Stage

Are you a biotech with cutting-edge innovation? Join the Presenting Company Class of 2025 to increase your visibility and drive partnering requests. Limited space - submit your nominations today.

Apply to Present >>

Share your Science

Showcase your cutting-edge translational science to top-tier investors and biopharma executives. Get in the room with the right people who can accelerate the path between your laboratory discoveries and the development of value-creating medicines.

Learn More >>